Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (1997) · Cytogenetic and Genome Research · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
Items 101–200 of 938
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
“This is particularly true for SDHA (PGL5) and SDHC (PGL3), for which penetrance appears to be much lower than for SDHB (PGL4) and SDHD (PGL1).”
BackgroundInfluentialPheochromocytoma: Current Approaches and Future Directions
Adler, J. T., Meyer-Rochow, G. Y., Chen, H., Benn, D. E., Robinson, B. G., Sippel, R. S., & Sidhu, S. B. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0043 · Cited by 197
King, K. S., Prodanov, T., Kantorovich, V., Fojo, T., Hewitt, J. K., Zacharin, M., Wesley, R., Lodish, M., Raygada, M., Gimenez-Roqueplo, A.-P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6353 · Cited by 196
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4057 · Cited by 194
Nuclear genetic defects of oxidative phosphorylation
Shoubridge, E. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2277 · Cited by 193
“Mutations in both SDHC and SDHD, encoding the large and small cytochrome b subunits, have been reported in families with autosomal dominant hereditary paraganglioma (PGL), a disorder characterized by the presence of benign, highly vascularized tumors of parasympathetic ganglia in the head and neck, most commonly occur…”
BackgroundWhole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
Cascón, A., Comino-Méndez, I., Currás-Freixes, M., de Cubas, A. A., Contreras, L., Richter, S., Peitzsch, M., Mancikova, V., Inglada-Pérez, L., Pérez-Barrios, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv053 · Cited by 192
Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology
Gill, A. J., Pachter, N. S., Chou, A., Young, B., Clarkson, A., Tucker, K. M., Winship, I. M., Earls, P., Benn, D. E., Robinson, B. G., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318227e7f4 · Cited by 191
“Key Words: SDHB, renal carcinoma, PGL4, hereditary renal carcinoma, GIST, paraganglioma, pheochromocytoma, onco- cytoma, clear cell carcinoma, gastrointestinal stromal tumor (Am J Surg Pathol 2011;35:1578–1585) Autosomal dominant germline mutations of succinatedehydrogenase B (SDHB), SDHC, and SDHD are established as…”
BackgroundAberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad
Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmeß, S., Wiemann, S., Bieg, M., Assie, G., Bertherat, J., Schaefer, I.-M., Otto, C., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0254 · Cited by 189
“Germline mutations in SDHC have been identified as a cause of familial PGL3 syndrome (Niemann & Müller 2000).”
Astrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., & Baysal, B. E. (2003) · Human Genetics · doi:10.1007/s00439-003-0969-6 · Cited by 187
“Mutations in SDHC (PGL3) and SDHB (PGL4) have subsequently been discovered in other paraganglioma families by direct candidate gene analyses (Niemann and Muller 2000; Astuti et al. 2001b).”
BackgroundMechanisms of mitochondrial diseases
Ylikallio, E., & Suomalainen, A. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.598547 · Cited by 185
Bayley, J.-P., Devilee, P., & Taschner, P. E. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-39 · Cited by 184
“A candidate gene approach quickly identified germline mutations in the other SDH subunits, SDHC (PGL3) [5] and SDHB (PGL4) [6].”
BackgroundThe metabolic basis of kidney cancer
Linehan, W. M., & Ricketts, C. J. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.002 · Cited by 144
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 178
Smestad, J., Erber, L., Chen, Y., & Maher, L. J. (2018) · iScience · doi:10.1016/j.isci.2018.03.012 · Cited by 151
“…(PPGL), gastrointestinal stromal tumor (GIST), renal cell carcinoma (RCC), thyroid cancer, and colon cancer (Agaimy, 2016; Astuti et al., 2001; Baysal et al., 2000; Gill et al., 2013; Nannini et al., 2014; Ni et al., 2015; Niemann and Müller, 2000; Pantaleo et al., 2015; Wang et al., 2016).”
BackgroundThe pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Dai, W., Xu, L., Yu, X., Zhang, G., Guo, H., Liu, H., Song, G., Weng, S., Dong, L., Zhu, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.015 · Cited by 174
Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor
Elder, E. E., Elder, G., & Larsson, C. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20177 · Cited by 173
“To date, susceptibility loci have been assigned to four distinct chromosomal regions; the PGL1 locus located in 11q23 [30], the PGL2 locus in 11q13 [31], the PGL3 locus in 1q21 [32], and the PGL4 locus in 1p36.”
BackgroundInfluentialOncometabolites‐driven tumorigenesis: From genetics to targeted therapy
Morin, A., Letouzé, É., Gimenez‐Roqueplo, A., & Favier, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29080 · Cited by 173
Brière, J.-J., Favier, J., Bénit, P., Ghouzzi, V. E., Lorenzato, A., Rabier, D., Di Renzo, M. F., Gimenez-Roqueplo, A.-P., & Rustin, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi359 · Cited by 152
“Originally, a subset of hereditary PGs were associated with mutations in the genes encoding SDH-anchoring subunits D and C (4,19).”
BackgroundHypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Jochmanova, I., Yang, C., Zhuang, Z., & Pacak, K. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt201 · Cited by 172
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Smith, E. H., Janknecht, R., & Maher, L. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm275 · Cited by 169
“Individuals who inherit a heterozygous mutation in SDHB, SDHC or SDHD are predisposed to familial PGL by subsequent loss of heterozygosity in neuroendocrine cells (3,4,28,29).”
BackgroundComino-Méndez, I., de Cubas, A. A., Bernal, C., Álvarez-Escolá, C., Sánchez-Malo, C., Ramírez-Tortosa, C. L., Pedrinaci, S., Rapizzi, E., Ercolino, T., Bernini, G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt069 · Cited by 169
Hensen, E. F., Jordanova, E. S., van Minderhout, I. J. H. M., Hogendoorn, P. C. W., Taschner, P. E. M., van der Mey, A. G. L., Devilee, P., & Cornelisse, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207591 · Cited by 169
Bayley, J.-P., van Minderhout, I., Weiss, M. M., Jansen, J. C., Oomen, P. H., Menko, F. H., Pasini, B., Ferrando, B., Wong, N., Alpert, L. C., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-1 · Cited by 166
“Subsequently, germline mutations in SDHC (PGL3-1q21) [6] and SDHB (PGL4-1p36) [7] were identified using a candidate gene approach, and both Astuti et al [7] and others [8-14] have reported that germline mutations of SDHB are involved in familial pheochromocytoma.”
BackgroundGenetic insights into OXPHOS defect and its role in cancer
Chandra, D., & Singh, K. K. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.023 · Cited by 151
“namely, SDHB, SDHC, and SDHD, have been involved in tumorigenesis [27,37,38].”
Taschner, P. E. M., Jansen, J. C., Baysal, B. E., Bosch, A., Rosenberg, E. H., Bröcker‐Vriends, A. H. J. T., van der Mey, A. G. L., van Ommen, G. B., Cornelisse, C. J., & Devilee, P. (2001) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.1144 · Cited by 165
“Subsequently, the SDHC gene was found to be PGL3 using a candidate gene approach (Niemann and Müller, 2000).”
MethodThe Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 142
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Burnichon, N., Buffet, A., Parfait, B., Letouzé, E., Laurendeau, I., Loriot, C., Pasmant, E., Abermil, N., Valeyrie-Allanore, L., Bertherat, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 148
“The present study was first focused on 53 tumor samples selected as follows: (1) lack of germline mutations in RET, VHL, SDHB, SDHC, SDHD, TMEM127 and MAX genes; (2) classification, by unsupervised hierarchical clustering analysis based on the gene expression, with tumors presenting RET, NF1 or TMEM127 germline mutati…”
BackgroundInfluentialSDHAF2 (PGL2-SDH5) and Hereditary Head and Neck Paraganglioma
Kunst, H. P. M., Rutten, M., de Mönnink, J. P., Hoefsloot, L. H., Timmers, H. J. L. M., Marres, H. A. M., Jansen, J. C., Kremer, H., Bayley, J., & Cremers, C. W. R. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0420 · Cited by 163
Bayley, J.-P., Launonen, V., & Tomlinson, I. P. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-20 · Cited by 162
“Mutations have been identified in both the gene encoding fumarate hydratase and three of the four genes encoding succinate dehydrogenase, subunits B, C and D (SDHB, -C and -D) [4-6], while no cancer-related mutations have yet been reported in SDHA.”
BackgroundTCA Cycle Defects and Cancer: When Metabolism Tunes Redox State
Cardaci, S., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/161837 · Cited by 161
van Hulsteijn, L. T., Dekkers, O. M., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101192 · Cited by 150
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Gimenez-Roqueplo, A.-P., Caumont-Prim, A., Houzard, C., Hignette, C., Hernigou, A., Halimi, P., Niccoli, P., Leboulleux, S., Amar, L., Borson-Chazot, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2975 · Cited by 159
“the disease in SDHD and SDHC in 2000 (8, 9), in SDHB”
BackgroundTargeting MTHFD2 in acute myeloid leukemia
Pikman, Y., Puissant, A., Alexe, G., Furman, A., Chen, L. M., Frumm, S. M., Ross, L., Fenouille, N., Bassil, C. F., Lewis, C. A., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151574 · Cited by 159
“…acid (TCA) cycle and electron transport chain, have been implicated in the pathogenesis of hereditary para-gangliomas (Baysal et al., 2000; Niemann and Müller, 2000), pheochromocytomas (Astuti et al., 2001), renal cell cancer (Vanharanta et al., 2004), and gastrointestinal stromal tumors…”
Malignant Head and Neck Paragangliomas in SDHB Mutation Carriers
Boedeker, C. C., Neumann, H. P. H., Maier, W., Bausch, B., Schipper, J. H., & Ridder, G. J. (2007) · Otolaryngology · doi:10.1016/j.otohns.2007.01.015 · Cited by 159
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156
“Recently, SDH genes have been considered as tumour suppressors since germ line inactivating mutations in the SDHB, C and D subunit genes can predispose individuals to hereditary paraganglioma (HPGL) [1,2] and phaeochromocytoma [3].”
BackgroundOncometabolites: tailoring our genes
Nowicki, S., & Gottlieb, E. (2015) · The FEBS Journal · doi:10.1111/febs.13295 · Cited by 143
Mitochondria in cancer: at the crossroads of life and death
Fogg, V. C., Lanning, N. J., & MacKeigan, J. P. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10018 · Cited by 155
Inborn and acquired metabolic defects in cancer
Frezza, C., Pollard, P. J., & Gottlieb, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0728-4 · Cited by 146
“A decade ago, heterozygous germline mutations in SDHB, SDHC, and SDHD subunits were identified as the causal tumor suppressor genes in hereditary paragangliomas and pheochromocytomas (hPGL), a rare hereditary cancer predisposition syndrome of the chromaffin tissue arising in the adrenal medulla pheochromocytoma (PCC)…”
BackgroundPediatric Gastrointestinal Stromal Tumors
Pappo, A. S., & Janeway, K. A. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2008.11.005 · Cited by 152
Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma
Muth, A., Crona, J., Gimm, O., Elmgren, A., Filipsson, K., Stenmark‐Askmalm, M., Sandstedt, J., Tengvar, M., & Tham, E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12869 · Cited by 151
Alston, C. L., Davison, J. E., Meloni, F., van der Westhuizen, F. H., He, L., Hornig‐Do, H., Peet, A. C., Gissen, P., Goffrini, P., Ferrero, I., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101146 · Cited by 151
Lactic acidemia and mitochondrial disease
ROBINSON, B. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.015 · Cited by 150
Mitochondria, from cell death to proliferation
Rustin, P. (2002) · Nature Genetics · doi:10.1038/ng0402-352 · Cited by 149
Loriot, C., Burnichon, N., Gadessaud, N., Vescovo, L., Amar, L., Libé, R., Bertherat, J., Plouin, P.-F., Jeunemaitre, X., Gimenez-Roqueplo, A.-P., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3437 · Cited by 123
“It included 58 nonmetastatic and 14 metastatic tumors (three of 11 SDHB, one of one SDHC, three of three VHL, two of two VHLs, and five of nine sporadic).”
BackgroundInfluentialJiménez, C., Cote, G., Arnold, A., & Gagel, R. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2178 · Cited by 137
Oxidative metabolism in cancer growth
Ristow, M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232892.43921.98 · Cited by 130
Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
Wagner, A. J., Remillard, S. P., Zhang, Y., Doyle, L. A., George, S., & Hornick, J. L. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.153 · Cited by 144
The role of mitochondria in the life of the nematode, Caenorhabditis elegans
Tsang, W. Y., & Lemire, B. D. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00079-6 · Cited by 140
McCammon, M. T., Epstein, C. B., Przybyla-Zawislak, B., McAlister-Henn, L., & Butow, R. A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0422 · Cited by 119
“…uterine fibroids, skin leiomyomata, and renal cell cancer (Tomlinson et al., 2002), whereas two types of brain tumors were found to be caused by mutations in three of the genes encoding subunits of succinate dehydrogenase (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001).”
BackgroundInfluentialAlterations of metabolic genes and metabolites in cancer
Oermann, E. K., Wu, J., Guan, K.-L., & Xiong, Y. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.013 · Cited by 119
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?
Lemarié, A., & Grimm, S. (2011) · Oncogene · doi:10.1038/onc.2011.167 · Cited by 140
“When the tumour-suppressor gene function of complex II subunits was discovered for SDHD, SDHC and SDHB (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001), two mechanisms were evoked to explain the oncogenesis process associated with complex II deficiency: (1) the establishment of…”
BackgroundInfluentialClinical aspects of SDHx-related pheochromocytoma and paraganglioma
Timmers, H. J. L. M., Gimenez-Roqueplo, A.-P., Mannelli, M., & Pacak, K. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0284 · Cited by 131
“A limited number of SDHC mutation carriers have been identified worldwide (Niemann & Muller 2000, Bauters et al .”
Parenti, G., Zampetti, B., Rapizzi, E., Ercolino, T., Giaché, V., & Mannelli, M. (2012) · Journal of Oncology · doi:10.1155/2012/872713 · Cited by 138
Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2
Boedeker, C. C., Erlic, Z., Richard, S., Kontny, U., Gimenez‐Roqueplo, A., Cascón, A., Robledo, M., de Campos, J. M., van Nederveen, F. H., de Krijger, R. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0354 · Cited by 138
Mitochondrial complex I is deficient in renal oncocytomas
Simonnet, H., Demont, J., Pfeiffer, K., Guenaneche, L., Bouvier, R., Brandt, U., Schägger, H., & Godinot, C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg109 · Cited by 138
Obre, E., & Rossignol, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.12.008 · Cited by 137
Inborn errors of complex II – Unusual human mitochondrial diseases
Rustin, P., & Rötig, A. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00228-6 · Cited by 135
Multi-site control and regulation of mitochondrial energy production
Bénard, G., Bellancé, N., José, C., Melser, S., Nouette‐Gaulain, K., & Rossignol, R. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.030 · Cited by 135
Bayley, J., & Devilee, P. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.02.008 · Cited by 131
Young, A. L., Baysal, B. E., Deb, A., & Young, W. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020312 · Cited by 125
Vascular malformations: localized defects in vascular morphogenesis
Brouillard, P., & Vikkula, M. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00092.x · Cited by 129
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
“Interestingly, mutations in the autosomally encoded enzyme and enzyme subunits are associated with hereditary predispositions to various tumors [77-80].”
BackgroundTaïeb, D., Nölting, S., Perrier, N. D., Faßnacht, M., Carrasquillo, J. A., Grossman, A. B., Clifton-Bligh, R. J., Wanna, G. B., Schwam, Z. G., Amar, L., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00926-0 · Cited by 128
Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer
Pinti, M., Gibellini, L., Liu, Y., Xu, S., Lü, B., & Cossarizza, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2039-3 · Cited by 126
Pillai, S., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.01.022 · Cited by 125
“In 2014, Oudijk et al. (2014) by means of Sanger sequencing determined the prevalence of Ras mutations in a cohort of 271 PCC/PGLs.”
MethodDesideri, E., Vegliante, R., & Ciriolo, M. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.023 · Cited by 124
Mitochondrial DNA Mutations Regulate Metastasis of Human Breast Cancer Cells
Imanishi, H., Hattori, K., Wada, R., Ishikawa, K., Fukuda, S., Takenaga, K., Nakada, K., & Hayashi, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023401 · Cited by 123
“, the Warburg effect, can be induced by mitochondrial respiration defects and can regulate tumor phenotypes, such as metastatic potential, by the induction of pseudo-hypoxic pathways under normoxia [8–11].”
Succinate dehydrogenase deficiency in human
Brière, J.-J., Favier, J., Ghouzzi, V. E., Djouadi, F., Bénit, P., Gimenez‐Roqueplo, A., & Rustin, P. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5237-6 · Cited by 120
Multisystem manifestations of mitochondrial disorders
Donato, S. D. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5028-3 · Cited by 118
Update on pediatric pheochromocytoma
Havekes, B., Romijn, J. A., Eisenhofer, G., Adams, K. T., & Pacák, K. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0888-9 · Cited by 116
Doyle, L. A., Nelson, D., Heinrich, M. C., Corless, C. L., & Hornick, J. L. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04300.x · Cited by 117
Evenepoel, L., Papathomas, T. G., Krol, N. M. G., Korpershoek, E., de Krijger, R. R., Persu, A., & Dinjens, W. N. M. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.162 · Cited by 115
Genetic insights into familial cancers – update and recent discoveries
Marsh, D. J., & Zori, R. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00023-x · Cited by 114
Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy
Badrinath, N., & Yoo, S. Y. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy148 · Cited by 114
The contribution of mitochondria to common disorders
Enns, G. M. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.009 · Cited by 112
SDH-related pheochromocytoma and paraganglioma
Kantorovich, V., King, K. S., & Pacák, K. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.04.001 · Cited by 113
“The two most recent additions to this group include mutations in SDH5 and propyl hydroxylase domain 2 (PDH2) genes (5,6) that, although extremely rare, are also associated with PHEOs/PGLs.”
BackgroundA role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
Acker, T., & Plate, K. H. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0355-1 · Cited by 112
“It was subsequently shown that the HIF system is constitutively activated in RCC lacking a functional pVHL. Loss of pVHL function leads to stabilization of HIF-α subunits already under normoxic conditions, while reintroduction of a functional VHL gene restored HIF regulation [33, 59].”
BackgroundInfluentialAstuti, D., Hart‐Holden, N., Latif, F., Lalloo, F. I., Black, G. C. M., Lim, C., Moran, A., Grossman, A. B., Hodgson, S. V., Freemont, A. J., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01914.x · Cited by 112
“Homozygous mutations in SDHA are a cause of Leigh syndrome (Bourgeron et al ., 1995; BirchMachin et al ., 2000) and a germline SDHC (1q21) mutation was described in a familial HNPGL family with no evidence of imprinting effects (Niemann & Muller, 2000).”
BackgroundRattenberry, E., Vialard, L., Yeung, A. C. Y., Bair, H., McKay, K., Jafri, M., Canham, N. L. E., Cole, T. R. P., Dénes, J., Hodgson, S. V., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1319 · Cited by 110
Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., & McCreath, K. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5580 · Cited by 98
Benn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206300 · Cited by 108
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation
Pęczkowska, M., Cascón, A., Prejbisz, A., Kubaszek, A., Ćwikła, J. B., Furmanek, M. I., Erlic, Z., Eng, C., Januszewicz, A., & Neumann, H. P. H. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0726 · Cited by 108
Mannelli, M., Lenders, J. W. M., Pacák, K., Parenti, G., & Eisenhofer, G. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.10.008 · Cited by 108
New targets and therapeutic approaches for endocrine malignancies☆
Fassnacht, M., Kreissl, M. C., Weismann, D., & Allolio, B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.013 · Cited by 107
Electron transport chain inhibition increases cellular dependence on purine transport and salvage
Wu, Z., Bezwada, D., Cai, F., Harris, R. C., Ko, B., Sondhi, V., Pan, C., Vu, H., Nguyen, P. T., Faubert, B., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.014 · Cited by 108
Head and neck paragangliomas: Report of 175 patients (1989–2010)
Papaspyrou, K., Mewes, T., Rossmann, H., Fottner, C., Schneider-Rätzke, B., Bartsch, O., Schreckenberger, M., Lackner, K. J., Amedee, R. G., & Mann, W. J. (2011) · Head & Neck · doi:10.1002/hed.21790 · Cited by 107
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
Baysal, B. E. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.004 · Cited by 106
Remacha, L., Comino‐Méndez, I., Richter, S., Contreras, L., Currás-Freixes, M., Pita, G., Letón, R., Galarreta, A., Torres‐Pérez, R., Honrado, E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2250 · Cited by 105
“Up to 40% of individuals with PCC and/or PGL have a hereditary background due to germline mutations affecting one of thirteen susceptibility genes (2-13).”
BackgroundFumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Tyrakis, P. A., Yurkovich, M. E., Sciacovelli, M., Papachristou, E. K., Bridges, H. R., Gaude, E., Schreiner, A., D’Santos, C. S., Hirst, J., Hernandez-Fernaud, J. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.092 · Cited by 105
Hereditary Paraganglioma/Pheochromocytoma and Inherited Succinate Dehydrogenase Deficiency
Favier, J., Brière, J.-J., Strompf, L., Amar, L., Filali, M., Jeunemaitre, X., Rustin, P., & Gimenez-Roqueplo, A.-P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000084685 · Cited by 88
“to report the first deleterious mutations in the SDHD gene, corresponding to the PGL1 locus. The use of a candidate gene approach has led to the identification of mutations in SDHC ( PGL3 )[”
BackgroundMitochondrial complex II, a novel target for anti-cancer agents
Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L., & Neuzil, J. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.015 · Cited by 104
“Genes coding for complex II (CII) subunits have received considerable attention in the context of cancer susceptibility genes since 2000, when first germline mutations in SDHD and SDHC were reported in families with hereditary paraganglioma (PGL) [51, 52].”
The genetics of paragangliomas: a review
Martin, T., Irving, R. M., & Maher, E. R. (2007) · Clinical Otolaryngology · doi:10.1111/j.1365-2273.2007.01378.x · Cited by 103
Multiple Endocrine Neoplasia Syndromes
Callender, G. G., Rich, T. A., & Perrier, N. D. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.05.001 · Cited by 103
Pseudohypoxic Pathways in Renal Cell Carcinoma
Bratslavsky, G., Sudarshan, S., Neckers, L., & Linehan, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2510 · Cited by 89
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 102
Pheochromocytoma – update on disease management
Därr, R., Lenders, J. W. M., Hofbauer, L. C., Naumann, B., Bornstein, S. R., & Eisenhofer, G. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437356 · Cited by 102
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory
Collins, R. R. J., Patel, K., Putnam, W. C., Kapur, P., & Rakheja, D. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.267666 · Cited by 90
Clinical implications of the oncometabolite succinate in SDHx ‐mutation carriers
Eijkelenkamp, K., Osinga, T. E., Links, T. P., & van der Horst‐Schrivers, A. N. A. (2019) · Clinical Genetics · doi:10.1111/cge.13553 · Cited by 103
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.